Insight by Science
Mislabeling persists because there are too few allergists, delabeling takes time and cross-specialty coordination, and no single specialty owns the problem, so capacity and incentives to scale testing never materialize.
Want more like this?
Every card on Korva is an insight someone saved from a podcast or video they loved.
More from this video
See all →A reliable blood test for penicillin allergy is hard to build because allergy-specific antibody levels fall or vary over time and current assays miss many true positives, so single blood panels show low sensitivity.
Aggressive pharmaceutical marketing and regulatory relabeling can inflate perceived allergy prevalence because expanding indications, lobbying, and normalization of rescue products increase diagnoses and prescriptions, which make the condition look more common.
